Pharma stock engaged in the business of manufacturing, marketing, trading, and selling a wide range of pharmaceutical products and formulations hits a 20 percent upper circuit in the day’s trade upon receiving a new work order worth Rs. 13.87 Crores
Price Action
With a market capitalization of Rs. 64.40 Crores, the shares of JFL Lifesciences Limited hit a 20 percent upper circuit in the day’s trade at Rs. 58.55 per equity share, from its previous day’s close price of Rs. 48.80.
What Happened
JFL Lifesciences Limited has received a new work order from Phil Capital Trading Solutions Inc. for a consideration of Rs. 13.87 Crores for the manufacturing and supply of Capsules in various tranches in a year at Manilla Port.
About the company
JFL Lifesciences Limited is engaged in the business of manufacturing, marketing, trading, and selling a wide range of pharmaceutical products and formulations across the global market.
Its main product categories include dry powder injections, solid oral dosage forms, tablets and capsules, Oral rehydration solutions (ORS), beta-lactam dry powder injection products, and many others.
Financials and Ratios
Its revenue from operations grew by 8.69 percent from Rs. 42.83 Crores in FY23 to Rs. 46.55 Crores in FY24, accompanied by profits of Rs. 2.81 Crores to Rs. 3.31 Crores.
In terms of Return ratios, it has reported a return on equity (ROE) of 10.3 percent, and a return on capital employed (ROCE) of 11.8 percent. It has reported a debt-to-equity ratio of 0.16.
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
